Showing 1001-1010 of 1354 results for "".
- Editorial Board/Contributorshttps://practicalneurology.com/columns/practice-management/editorial-boardcontributors/31351/Exploring Advanced Neurological Practices: Insights from Leading ExpertsIn the latest issue of *Practical Neurology*, healthcare professionals are presented with a comprehensive collection of articles curated by an esteemed editorial board and a cadre of distinguished contributors. This edition delv
- Bad Reception: When MS Patients Are on a Different Wavelengthhttps://practicalneurology.com/columns/practice-management/bad-reception-when-ms-patients-are-on-a-different-wavelength/31064/Enhancing Physician-Patient Relationships to Improve MS Patient RetentionMaintaining strong physician-patient alliances is crucial in managing Multiple Sclerosis (MS), a chronic and unpredictable neurological disorder. According to a January 2008 article in Practical Neurology, MS patients frequentl
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31191/Advancements in Neurology: Key Developments in Epilepsy Management and BeyondRecent breakthroughs in epilepsy care are equipping neurologists with enhanced therapeutic options and optimizing existing treatments. A pivotal study published in the April 10th issue of *Neurology* highlights the efficacy
Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury-1/32192/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Neuromuscular Notes: New and Emerging Therapies in ALS
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-new-and-emerging-therapies-in-als/32007/New therapies—including antisense oligonucleotides, mesenchymal stem cells, and kinase inhibitors—are in development to target specific pathogenic mechanisms identified in ALS.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/imaging-testing/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury/32184/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Dystrophinopathies and the Limb-Girdle Muscular Dystrophies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/dystrophinopathies-and-the-limb-girdle-muscular-dystrophies/32028/Disease management for dystrophinopathies and limb-girdle muscular dystrophies has evolved from palliation to genetic therapeutics, paving the way toward a cure.Migraine Preventive Therapies
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-preventive-therapies/31511/With new—and first-in-class—migraine-specific treatments, preventive treatment of migraine is changing quickly.Critical Care Management of the Acute Ischemic Stroke Patient
https://practicalneurology.com/diseases-diagnoses/stroke/critical-care-management-of-the-acute-ischemic-stroke-patient/30842/Care of a patient with AIS is comprehensive and requires a team approach. Clinicians must be able to control and influence a multitude of physiologic parameters in order to assure optimal outcome.Migraine and the Presidency: Clinical Lessons from History?
https://practicalneurology.com/columns/practice-management/migraine-and-the-presidency-clinical-lessons-from-history/30790/History reveals some interesting facts about migraine, perceptions of chronic headaches, and the impact of migraine on the power to lead